MENU

ABUS Arbutus Biopharma Corp Forecast, Technical & Fundamental Analysis

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases... Show more

Industry: #Biotechnology
ABUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
ABUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ABUS is expected to report earnings to fall 33.33% to -1 cents per share on November 11

Arbutus Biopharma Corp ABUS Stock Earnings Reports
Q3'26
Est.
$-0.02
Q2'26
Est.
$-0.03
Q1'26
Beat
by $0.91
Q4'25
Missed
by $0.14
Q3'25
Missed
by $0.01
The last earnings report on August 12 showed earnings per share of -2 cents, meeting the estimate of -2 cents. With 4.26M shares outstanding, the current market capitalization sits at 962.79M.
A.I. Advisor
published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
19
Web
http://www.arbutusbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMPY4.380.17
+4.04%
Amplify Energy Corp
VWAV4.490.07
+1.58%
Visionwave Holdings Inc
TDW82.181.08
+1.33%
Tidewater
LYV166.85-2.45
-1.45%
Live Nation Entertainment
SABR1.99-0.13
-6.13%
Sabre Corp

ABUS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABUS has been loosely correlated with ARRY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ABUS jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABUS
1D Price
Change %
ABUS100%
-4.60%
ARRY - ABUS
43%
Loosely correlated
-3.47%
AXON - ABUS
42%
Loosely correlated
-0.07%
KURA - ABUS
42%
Loosely correlated
-0.56%
RCKT - ABUS
42%
Loosely correlated
-1.52%
PCVX - ABUS
41%
Loosely correlated
-1.49%
More
Arbutus Biopharma (ABUS) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com